CN115336691A - Preparation method of health-preserving composite tea rich in Chinese herbal medicine components - Google Patents
Preparation method of health-preserving composite tea rich in Chinese herbal medicine components Download PDFInfo
- Publication number
- CN115336691A CN115336691A CN202211010440.6A CN202211010440A CN115336691A CN 115336691 A CN115336691 A CN 115336691A CN 202211010440 A CN202211010440 A CN 202211010440A CN 115336691 A CN115336691 A CN 115336691A
- Authority
- CN
- China
- Prior art keywords
- parts
- health
- preparation
- herbal medicine
- chinese herbal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001122767 Theaceae Species 0.000 title claims description 46
- 239000002131 composite material Substances 0.000 title claims description 21
- 241000411851 herbal medicine Species 0.000 title claims description 14
- 238000002360 preparation method Methods 0.000 title claims description 13
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 41
- 240000000249 Morus alba Species 0.000 claims abstract description 40
- 239000000284 extract Substances 0.000 claims abstract description 28
- 230000036541 health Effects 0.000 claims abstract description 22
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 20
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 19
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 19
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 19
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 19
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 19
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 19
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 19
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 19
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 19
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 19
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 17
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 claims abstract description 16
- 241001533085 Aquilaria sinensis Species 0.000 claims abstract description 13
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 10
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 4
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims abstract description 4
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 3
- 239000002994 raw material Substances 0.000 claims abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 241000229143 Hippophae Species 0.000 claims description 13
- 241001092459 Rubus Species 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 7
- 235000013361 beverage Nutrition 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 235000003935 Hippophae Nutrition 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 238000004537 pulping Methods 0.000 claims description 4
- 238000002137 ultrasound extraction Methods 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000005057 refrigeration Methods 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 230000007306 turnover Effects 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims 1
- 238000007670 refining Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 46
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 230000001737 promoting effect Effects 0.000 abstract description 14
- 210000000952 spleen Anatomy 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 235000009508 confectionery Nutrition 0.000 abstract description 3
- 210000002784 stomach Anatomy 0.000 abstract description 3
- 240000000950 Hippophae rhamnoides Species 0.000 abstract description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 235000019640 taste Nutrition 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 4
- 231100000331 toxic Toxicity 0.000 abstract 2
- 230000002588 toxic effect Effects 0.000 abstract 2
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 45
- 102000019197 Superoxide Dismutase Human genes 0.000 description 20
- 108010012715 Superoxide dismutase Proteins 0.000 description 20
- 241000699670 Mus sp. Species 0.000 description 17
- 241001092040 Crataegus Species 0.000 description 16
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 16
- 229940118019 malondialdehyde Drugs 0.000 description 16
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 238000003304 gavage Methods 0.000 description 9
- 230000003078 antioxidant effect Effects 0.000 description 8
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 6
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 6
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 6
- 230000005176 gastrointestinal motility Effects 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 230000008855 peristalsis Effects 0.000 description 6
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 6
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 229930002877 anthocyanin Natural products 0.000 description 5
- 235000010208 anthocyanin Nutrition 0.000 description 5
- 239000004410 anthocyanin Substances 0.000 description 5
- 150000004636 anthocyanins Chemical class 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000012449 Kunming mouse Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 240000000491 Corchorus aestuans Species 0.000 description 3
- 235000011777 Corchorus aestuans Nutrition 0.000 description 3
- 235000010862 Corchorus capsularis Nutrition 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 150000002212 flavone derivatives Chemical class 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000218231 Moraceae Species 0.000 description 2
- -1 Superoxide anion free radical Chemical class 0.000 description 2
- 235000014590 basal diet Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 235000009200 high fat diet Nutrition 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 102000012336 Cholesterol Ester Transfer Proteins Human genes 0.000 description 1
- 108010061846 Cholesterol Ester Transfer Proteins Proteins 0.000 description 1
- 108010004103 Chylomicrons Proteins 0.000 description 1
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102100033053 Glutathione peroxidase 3 Human genes 0.000 description 1
- 101710119049 Glutathione peroxidase 3 Proteins 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides health tea which is prepared from the following components in parts by weight: 0.1-4.31 parts of stevia rebaudiana, 0.1-7.83 parts of mulberry extract, 0.1-3.23 parts of seabuckthorn fruit, 0.1-2.52 parts of fingered citron, 0.1-5.69 parts of aquilaria sinensis leaf, 0.1-3.56 parts of coix seed powder, 0.1-5.78 parts of hawthorn and medicinal and edible natural components serving as raw materials of the health tea, and a plurality of medicinal and edible natural components are organically combined in a compatible mode, so that the health tea is easy to absorb by a human body, fragrant in smell, sweet in taste, safe, free of toxic and side effects, simple in formula, harmonious in attributes of the raw materials, scientific, reasonable and mild in medicinal properties. The health tea has effects of clearing away heat and toxic materials, caring skin, invigorating spleen and stomach, regulating intestinal tract, promoting blood circulation, removing blood stasis, and promoting health.
Description
Technical Field
The invention relates to the technical field of health-care beverages, in particular to health-care composite tea which has the effects of reducing high blood pressure, high blood sugar and high blood lipid and resisting oxidation and is rich in Chinese herbal medicine components.
Background
Tea leaves originated in china, and were the earliest used as sacrificial offerings. However, the beverage is eaten by people in the late spring and autumn, is developed into a medicinal food in the middle of Western Han, is developed into a palace high-grade beverage in the later period of Western Han, and is popularized among people as a common beverage which is the thing after the West jin. The ancient site of tea leaves planted artificially in Tianlushan mountain of Yuyao, zhejiang has been found to have a history of more than 6000 years. Tea drinking begins in china. The leatheroid is oblong or elliptical, can be directly soaked and drunk by boiled water, and is divided into six categories according to variety, manufacturing mode and product appearance. The tea can be spring tea, summer tea, autumn tea and winter tea according to the seasons. Various raw tea or refined tea is processed into tea, including scented tea, compressed tea, extracted tea, medicinal health tea, tea food, tea-containing beverage, etc.
The anti-aging effect of hawthorn belongs to the genus hawthorn of the family of hawthorn and rosaceous and is at the head of the fruit group. Hard stone, thin pulp, slightly sour and astringent taste. The fruit can be eaten raw or used as a preserved fruit cake, can be used as a medicine after being dried, is a tree species which is a special Chinese medicine and fruit, has the effects of reducing blood fat, blood pressure, strengthening heart, resisting arrhythmia and the like, is also a good medicine for strengthening spleen, stimulating appetite, promoting digestion, removing food stagnation, promoting blood circulation and reducing phlegm, and has good curative effects on chest, diaphragm and spleen fullness, hernia, blood stasis, amenorrhea and other symptoms. The flavone compound vitexin in hawthorn is a component with strong anticancer effect, and its extract has a certain action for inhibiting growth, proliferation and infiltration metastasis of cancer cells in vivo.
The root, stem, leaf, flower and fruit of fingered citron can be used as the medicine, and are pungent, bitter, sweet, warm and nontoxic; it has the functions of regulating qi, eliminating phlegm, stopping vomiting, relieving flatulence, soothing liver, strengthening spleen, regulating stomach and other medicinal functions. Has obvious relieving effect on tracheitis and asthma of the old; has more obvious curative effect on dyspepsia and chest and abdomen swelling and stuffiness of general people. The fingered citron can be made into various natural component materials with homology of medicine and food, and has the functions of health care and life prolonging after long-term use.
Mulberry is the fruit cluster of Moraceae plant, also known as Mulberry. Traditional Chinese medicine holds that mulberry is cold in nature and sweet in taste, has the effects of nourishing yin, enriching blood, improving eyesight, blackening hair, beautifying, treating insomnia and neurasthenia, resisting fatigue, preventing and treating constipation and the like, and can prolong life after being eaten for a long time. Modern medical research shows that the mulberry has the effects of enhancing the immunologic function, promoting the growth of hematopoietic cells, preventing human arteriosclerosis and the like, also has the effects of resisting mutation, viruses, oxidation, aging and the like, and is rich in polyphenols, particularly anthocyanin components, vitamins and the like.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to prepare the health-preserving compound tea rich in Chinese herbal medicine components, and the health-preserving compound tea has the functions of resisting oxidation, reducing high blood pressure, high blood sugar and high blood lipid and promoting gastrointestinal motility.
The invention provides a health-preserving composite tea rich in Chinese herbal medicine components, and the health-preserving composite tea comprises the following components: hawthorn, rubus suavissimus, mulberry, seabuckthorn fruit, fingered citron, aquilaria sinensis leaf and coix seed powder.
The health-preserving composite tea is prepared from the following components in parts by weight: 0.1 to 4.31 portions of rubus suavissimus, 0.1 to 7.83 portions of mulberry extract, 0.1 to 3.23 portions of seabuckthorn fruit, 0.1 to 2.52 portions of fingered citron, 0.1 to 5.69 portions of aquilaria sinensis leaf, 0.1 to 3.56 portions of coix seed powder and 0.1 to 5.78 portions of hawthorn.
The second aspect provides a preparation method of health-preserving composite tea rich in Chinese herbal medicine components, which comprises the following steps:
(1) Preparing a mulberry extract;
(2) Preparing coix seed powder:
(3) Screening fructus Rubi Corchorifolii Immaturus, fructus Hippophae, fructus Citri Sarcodactylis, and folium Aquilariae Resinatum, washing with water, dehydrating, drying, parching with slow fire, pulverizing, and sieving;
(4) Pulverizing fructus crataegi, mixing with the above materials at a certain weight ratio, granulating, and packaging.
The preparation method of the mulberry extract comprises the following steps:
weighing fresh mulberry fruits, pulping, adding distilled water, performing ultrasonic-assisted extraction at normal temperature, filtering the extraction solution, and concentrating the filtrate under reduced pressure to obtain red paste extracts respectively.
The preparation method of the coix seed powder comprises the following specific steps:
cleaning clean whole-grain coix seeds, draining, drying in a drying oven at 50 +/-1 ℃ to constant weight, coarsely grinding by a universal grinder, sieving by a 60-mesh sieve, and grinding by a fine grinder. The lapping machine has an amplitude of 5.5mm, a turnover type working mode, and a circulating refrigeration system at room temperature of 25-28 deg.C, and is pulverized by high-frequency vibration for 1min.
The mulberry contains a large amount of nutritional ingredients such as protein, fat, flavonoid, anthocyanin and polyphenol. Constipation is the most common disease of the digestive tract in clinic, and the symptoms can be effectively relieved by taking some dietary fibers. According to the research team, the mulberry and the jute are mixed together and are subjected to compound proportioning, so that the effects of relaxing bowel are achieved.
The invention group finds that the hawthorn contains a large amount of quercetin-3-O-beta-D- 4 C 1 The galactoside (hyperin) has an effect on anthocyanin in the mulberry, so that the hyperin can play a role in increasing the content of glutathione and improving the activity of superoxide dismutase, and the antioxidant capacity of the sample prepared in the embodiment of the invention is improved. At the same time, hyperin is combined with the binding sites of COX-I and COX-II enzymes, and the COX-I and COX-II enzymes can regulate the physiological activities of normal tissue cells, change the vascular tension and regulate the blood pressure of human bodies.
Compared with the prior art, the invention has the following beneficial effects:
1. the coix seeds are combined with the components such as the mulberries, the finger citron and the like, so that the effects of tonifying spleen and clearing damp can be better achieved.
2. According to the invention, the mulberry extract is combined with the hawthorn, so that the health tea prepared by the invention has the functions of promoting intestinal peristalsis and relaxing bowel.
3. The hawthorn flavone acts together with anthocyanins and mulberry flavonoids in mulberry, so that the content of Malondialdehyde (MDA) in serum and liver can be remarkably reduced, the activity of erythrocyte and liver superoxide dismutase (SOD) is enhanced, and the activity of plasma glutathione peroxidase (GSH-Px) is enhanced.
4. The hawthorn flavone and the polyphenol in the mulberry in the invention play roles together, so that the invention has obvious effects of promoting blood circulation and removing blood stasis, has a certain function of raising blood pressure for patients suffering from long-term hypotension, and also has a certain effect of maintaining beauty and keeping young.
Drawings
FIG. 1 is a graph showing the effect of the samples of the present invention on the activities of superoxide dismutase and malondialdehyde.
FIG. 2 is a graph showing the effect of morpholine on gastrointestinal motility in example 1 and comparative examples 1 to 6.
FIG. 3 is a graph showing binding sites of hyperoside to COX-I and COX-II enzymes in the present invention.
Detailed Description
The embodiments of the present invention are described below with reference to specific embodiments, and other advantages and effects of the present invention will be easily understood by those skilled in the art from the disclosure of the present specification. The invention is capable of other and different embodiments and of being practiced or of being carried out in various ways, and its several details are capable of modification in various respects, all without departing from the spirit and scope of the present invention. It should be noted that the features in the following embodiments and examples may be combined with each other without conflict.
Example 1
Weighing 50.0g of fresh mulberry fruit, pulping, adding 200mL of distilled water, performing ultrasonic-assisted extraction at normal temperature for 40min, filtering the extraction solution, and concentrating the filtrate under reduced pressure to obtain red paste extracts, namely mulberry extracts.
Cleaning 50g of clean whole-grain coix seeds, draining, drying in a drying oven at 50 +/-1 ℃ to constant weight, coarsely grinding by a universal grinder, sieving by a 60-mesh sieve, and grinding by a fine grinder. The lapping machine has an amplitude of 5.5mm, a turnover type working mode, and a circulation refrigeration system at 25 deg.C for 1min.
Screening 50g of stevia rebaudiana, fructus Hippophae, fructus Citri Sarcodactylis and Aquilaria sinensis, washing with water, dehydrating, drying, parching with slow fire, pulverizing, and sieving.
And (3) mixing the sieved rubus suavissimus, fructus hippophae, fingered citron and aquilaria sinensis leaves with the mulberry extract, the coix seed powder and the hawthorn in parts by weight, preparing into 80-mesh particles after mixing, and packaging, wherein each bag contains 4g of the particles, so as to obtain the health-preserving composite tea.
The weight portions are as follows: 2.36 parts of rubus suavissimus, 5.82 parts of mulberry extract, 2.13 parts of sea buckthorn fruit, 1.28 parts of fingered citron, 3.45 parts of aquilaria sinensis leaves, 1.02 parts of coix seed powder and 4.26 parts of hawthorn.
Example 2
The procedure of example 2 is substantially the same as in example 1, except that in example 2, the parts by weight are: 4.08 parts of stevia rebaudiana, 6.25 parts of mulberry extract, 3.09 parts of sea buckthorn fruit, 0.78 parts of fingered citron, 3.12 parts of aquilaria sinensis leaves, 1.25 parts of coix seed powder and 3.21 parts of hawthorn.
Example 3
The procedure of example 3 is substantially the same as in example 1, except that in example 3, the parts by weight are: 3.25 parts of rubus suavissimus, 3.58 parts of mulberry extract, 0.55 part of seabuckthorn fruit, 1.81 parts of fingered citron, 4.77 parts of aquilaria sinensis leaf, 3.21 parts of coix seed powder and 2.83 parts of hawthorn.
Example 4
The procedure of example 4 is substantially the same as in example 1, except that in example 4 the following are used in parts by weight: 4.31 parts of rubus suavissimus, 7.83 parts of mulberry extract, 3.23 parts of seabuckthorn fruit, 2.52 parts of fingered citron, 5.69 parts of aquilaria sinensis leaf, 2.38 parts of coix seed powder and 4.04 parts of hawthorn.
Comparative example 1
The procedure of comparative example 1 was substantially the same as example 1, except that the composite health tea prepared in comparative example 1 was not added with the mulberry extract.
Comparative example 2
Comparative example 2 was substantially the same as example 1, except that the composite health tea prepared in comparative example 2 was prepared without adding the coix seed powder.
Comparative example 3
Comparative example 3 was substantially the same as example 1, except that the composite health tea prepared in comparative example 3 was prepared without adding the coix seed powder and the mulberry extract.
Comparative example 4
Comparative example 4 was substantially the same as example 1 except that only hawthorn was added to the health preserving composite tea prepared in comparative example 4.
Comparative example 5
Comparative example 5 was substantially the same as example 1, except that the coix seed in the health composite tea prepared in comparative example 5 was not ground.
Comparative example 6
Comparative example 6 was substantially the same as example 1, except that the mulberry extract was prepared in comparative example 6 by the steps of: weighing 50.0g of fresh mulberry fruit, pulping, adding 200mL of acetone, performing ultrasonic-assisted extraction at normal temperature for 40min, filtering the extraction solution, and concentrating the filtrate under reduced pressure to obtain red paste extracts, namely mulberry extracts.
Detection of antioxidant Properties
Determination of superoxide dismutase and malondialdehyde
1. Materials and methods
1.1 animal: healthy Kunming mice, female, with the weight of 18 plus or minus 2g, are fed with common feed and freely drink water.
1.2 Experimental materials, instruments
The samples prepared in examples 1 to 4 and comparative examples 1 to 6 (4 g of tea bags per bag) were soaked in 100mL of water for 30min, D-galactose: sigma company; superoxide dismutase (SOD) test kit, malondialdehyde (MDA) test kit; 80% of ginsenoside.
1.3 Experimental methods
Taking 120 female mice, randomly dividing the mice into 12 groups, 10 mice in each group, and making no statistical difference among the groups, namely, gavage distilled water (0.1 mL/10 g.day) for a normal control group, gavage distilled water (0.1 mL/10 g.day) for a model group, gavage distilled water (0.1 mL/10 g.day) for a positive drug control group, gavage ginseng saponin (0.1 mL/10 g.day) for an example 1 group, gavage sample (0.1 mL/10 g.day) for an example 2 group, gavage sample (0.1 mL/10 g.day) for an example 3 group, gavage sample (0.1 mL/10 g.day) for an example 4 group, gavage sample (0.1 mL/10 g.1 g.10 day) for an example 1 group, gavage sample for a comparative example 5 g.5 g.10 day, and sample for a comparative example 1 group; meanwhile, the model group, the positive control group and the sample group were injected subcutaneously at the back of the neck with D-galactose at 1250 mg/kg-day. All groups were fed with normal feed and water was allowed to drink freely. After continuous administration for 6 weeks, each group of mice was subjected to eyeball-removal blood collection, centrifuged at 3000r/min for 15min, and the serum SOD activity and MDA content were measured. SOD activity and MDA content were measured spectrophotometrically according to the kit instructions. There was no statistical difference between groups.
2. Results
The effect of the samples on mouse serum SOD and MDA is shown in Table 1.
TABLE 1 Effect of samples on mouse serum SOD, MDA
Group of | SOD activity (U.mg) -1 ) | MDA Activity (U. Mg) -1 ) |
Blank control group | 144.16±2.81 | 16.74±0.31 |
Model set | 137.80±1.48 | 17.71±0.23 |
Positive control group | 157.18±1.49 | 14.53±0.10 |
EXAMPLE 1 group | 163.38±1.37 | 13.27±0.19 |
EXAMPLE 2 group | 162.35±1.56 | 14.23±0.11 |
EXAMPLE 3 group | 159.89±1.88 | 14.35±0.28 |
EXAMPLE 4 group | 160.31±1.25 | 14.26±0.15 |
Comparative example 1 group | 135.26±2.20 | 17.26±0.08 |
Comparative example 2 group | 145.66±2.02 | 15.64±0.21 |
Comparative example 3 group | 139.77±1.58 | 17.58±0.16 |
Comparative example 4 group | 138.56±2.35 | 17.72±0.15 |
Comparative example 5 group | 140.25±1.36 | 16.89±0.08 |
Comparative example 6 group | 138.72±1.25 | 16.23±0.14 |
Table 1 shows the effect of the samples on mouse serum SOD and MDA. Superoxide Dismutase (SOD) is an antioxidant metalloenzyme existing in organisms, can catalyze Superoxide anion free radical disproportionation to generate oxygen and hydrogen peroxide, plays a vital role in body oxidation and antioxidant balance, and is inseparable from the occurrence and development of a plurality of diseases. The final product of lipid oxidation is Malondialdehyde (MDA), which in the human body affects the activity of key enzymes in mitochondria in human cells and is a substance carcinogenic to the human body. D-galactose can cause the SOD activity to be reduced, the MDA activity to be increased and the like, thereby causing the brain function to be declined. As can be seen from Table 1, the activity of superoxide dismutase is enhanced and the activity of malondialdehyde is reduced in the samples prepared in the example group and the positive control group, which shows that the samples prepared in the example group have obvious antioxidant effect on human bodies. In addition, from the data of the samples in the group of example 1 and the samples in the groups of comparative examples 1 to 3, the activity enhancement effect of the sample without adding the mulberry extract on superoxide dismutase is not obvious, which indicates that the mulberry extract plays a crucial role in the antioxidant link. Comparison of the data of example 1 and comparative examples 1-4 shows that the mulberry extract has a significant synergistic effect with the rubus suavissimus, fructus hippophae, fingered citron and aquilaria sinensis leaves, which indicates that the rubus suavissimus, the hippophae rhamnoides, the fingered citron and the aquilaria sinensis leaves have a certain promoting effect on active ingredients in mulberry, so that the sample prepared in example 1 has a significant antioxidant effect. The reason is that anthocyanins in the mulberry extract react with hyperoside in jute, so that hyperoside is combined with COX-i and COX-ii enzyme binding sites, which enables glutathione content to be increased and superoxide dismutase activity to be increased. The improvement of the activity of superoxide dismutase can reduce free radicals in vivo and has better antioxidant effect.
Detection of effect of promoting gastrointestinal peristalsis
1. Materials and methods
1.1 materials
Animals: female Kunming mouse, weight 18 + -2 g, fasting for 20h.
The samples prepared in example 1 and comparative examples 1-6 (4 g tea bags per bag) were soaked in 100mL of water for 30min.
1.2 methods
90 Kunming white mice were fasted for 20 hours and randomly divided into 9 groups, i.e., a control group, example 1 group, comparative examples 1-6 group, and a morpholine group, 10 animals per group, with no statistical difference between the groups, and labeled with picric acid. The samples (20.0 mg/kg) of the group of example 1, the groups (20.0 mg/kg) of comparative examples 1 to 6 and the morpholine solution (3.9 mg/kg) were individually subjected to intragastric administration, the control group was subjected to intragastric administration with an equal amount of physiological saline, and after 90 minutes, each group was subjected to intragastric administration with 0.3mL of black juice. After 20 minutes, the cervical vertebrae are killed by dislocation, the abdominal cavity is opened to separate intestinal membranes, the intestinal canal is cut from the upper end to the pylorus and from the lower end to the ileocecal part, the small intestine is placed on a tray and slightly pulled into a straight line, and the length of the intestinal canal is measured to be used as the total length of the small intestine. The distance from the pylorus to the leading edge of the ink serves as "the ink advancing distance in the intestine". The percent ink advance was calculated using the formula. Ink propulsion rate (%) = ink propulsion distance in intestine (cm)/total length of small intestine (cm) × 100%. There was no statistical difference between groups. The results of the comparison of the intestinal transit function of each group of mice are shown in Table 2.
TABLE 2 Effect of samples on gastrointestinal motility
Table 2 shows that the influence of the sample on the gastrointestinal peristalsis is that the advancing rate of the gastrointestinal peristalsis of the morpholine group is as high as 86.48, the advancing rate of the gastrointestinal peristalsis of the group in example 1 is 83.01, and the effect of promoting the gastrointestinal peristalsis of the group in comparison is not very obvious. It is obvious from the data of the positive control group, namely the morpholine group and the example 1 group, that the sample prepared by the method has a remarkable effect on promoting gastrointestinal motility, and the reason is probably that the sample prepared by the method contains a large amount of dietary fibers, so that the gastrointestinal motility can be effectively promoted, the intestinal condition is improved, and the purpose of relaxing bowel is achieved. As can be seen from the comparison of the data of the example 1 group and the comparative example group, the samples prepared in the example group are less than the same, and the effect of promoting the gastrointestinal motility is greatly reduced. The synergistic effect among the components of the mulberry extract, the jute, the fingered citron and the like is proved, so that the sample effect of the embodiment group prepared by the invention is obvious.
Blood lipid level detection
1 materials and methods
1.1 materials
Animals: 80 male-grade Kunming mice with the body weight of 20 +/-1 g. Before the formal test, adaptive feeding is needed for 7 days, the feeding environment is air-conditioned and constant temperature, the temperature is 20 +/-2 ℃, the relative humidity is 50-80%, the natural lighting is realized, the ventilation is frequent, the mice can freely eat and drink water, the drinking water is changed every day, and the padding is changed for 3 times every week.
Health tea: examples 1-2 samples prepared according to the invention and samples prepared according to comparative examples 1-4.
1.2 test methods
(1) The samples of examples 1-2 prepared according to the present invention and the samples prepared according to comparative examples 1-4 (4 g of tea bags per bag) were soaked in 100mL for 30min.
(2) 80 Kunming mice with the age of 8 weeks, the weight of 20 +/-1 g, after being adaptively raised for one week, are randomly divided into 8 groups, 10 mice in each group are respectively a normal group, an example 1 group, an example 2 group, a comparative example 1 group, a comparative example 2 group, a comparative example 3 group, a comparative example 4 group and a model group, and no statistical difference exists among the groups.
(3) The test is divided into two stages, the first stage is an adaptation stage, and all mice are fed with basic feed in the stage; the second phase is an intervention treatment phase, which is 7 days, in which the normal group is fed basal diet and the other groups are fed high fat diet (high fat diet formulation: 78.9% basal diet +0.1% porcine bile salts +10% lard +10% egg yolk powder).
In the second phase, the mice in each group were gavaged at 0.2mL/10g,1 time/day, with free access to food and water. The normal group (group) and the model group were filled with sterilized distilled water, and the tea water prepared by filling the stomach of the samples of examples 1-2 and comparative examples 1-4, respectively.
(4) Test mouse samples were collected and fed to the same time period at day 2841. The mice in each group are fasted 12h before the collection of the sample, 400 microliter blood is collected when the mice pick eyeballs and collect blood, the blood is dropped into a common centrifuge tube, the centrifuge tube is placed into a 37 ℃ incubator for 30min to fully separate out serum, and then the centrifuge tube is placed into a centrifuge for centrifugation for 3min at 4 ℃ and 12000r/min. The serum sample is analyzed by a full-automatic biochemical analyzer.
2. Results of the experiment
TABLE 3 results of the peripheral blood lipid assay in hyperlipidemic mice
As can be seen from table 3, the serum total cholesterol of the mice of the model group, the example group and the comparative example group was very significantly different from that of the normal group. And the serum total cholesterol index of the example 1 group and the example 2 group is reduced by 12.28 percent and 11.70 percent respectively compared with the model group. Compared with the model group, the total cholesterol content in the serum of the mice is almost unchanged in the comparative example group, which shows that the sample in the comparative example group has no obvious effect on reducing the cholesterol.
From the measurement results of the triglyceride content of mice, the model group and the example group were significantly different from the normal group, while the comparative example group was not significantly different from the normal group, which shows that the samples of the example group prepared by the present invention have a significant effect on the reduction of triglyceride in the blood of mice. The example group and the model group have significant difference in low density lipoprotein cholesterol, but have little influence on high density lipoprotein cholesterol. The reason may be that the rise of the cholesterol content of the high density lipoprotein is probably because the corresponding stress increase of the high density lipoprotein is caused by the surge of the blood fat content, thereby relieving the metabolic regulation pressure of the blood fat in vivo; on the other hand, it is possible that the content is increased due to the decrease in the content of cholesteryl ester transfer protein, and is an important regulatory factor capable of promoting the exchange between cholesteryl ester in the medium and the very low density lipoprotein and chylomicron, resulting in the cholesterol being slowly migrated therefrom, and the particle size being reduced.
Finally, it should be noted that: the above embodiments only express specific embodiments of the present invention, and the description is specific and detailed, but not to be understood as limiting the scope of the present invention. It should be noted that various changes and modifications can be made by those skilled in the art without departing from the spirit of the invention, and these changes and modifications are all within the scope of the invention.
Claims (8)
1. A health-preserving composite tea rich in Chinese herbal medicine components is characterized in that the tea is a beverage product formed by mixing hawthorn as a matrix with a plurality of components including rubus suavissimus, mulberry, seabuckthorn fruit, fingered citron, aquilaria sinensis leaves and coix seed powder.
2. The health preserving composite tea rich in Chinese herbal medicine components as claimed in claim 1, which is characterized in that: the weight of each raw material is as follows: 0.1 to 4.31 portions of stevia rebaudiana, 0.1 to 7.83 portions of mulberry extract, 0.1 to 3.23 portions of seabuckthorn fruit, 0.1 to 2.52 portions of fingered citron, 0.1 to 5.69 portions of aquilaria sinensis leaf, 0.1 to 3.56 portions of coix seed powder and 0.1 to 5.78 portions of hawthorn.
3. The preparation method of the health preserving composite tea rich in Chinese herbal medicine components as claimed in claim 1, is characterized in that:
(1) Preparing a mulberry extract;
(2) Preparing coix seed powder;
(3) Screening fructus Rubi Corchorifolii Immaturus, fructus Hippophae, fructus Citri Sarcodactylis, and folium Aquilariae Resinatum, washing with water, dehydrating, drying, parching with slow fire, pulverizing, and sieving;
(4) Pulverizing fructus crataegi, mixing with the above materials at a certain weight ratio, granulating, and packaging.
4. The preparation method of the health preserving composite tea rich in Chinese herbal medicine components according to claim 3, characterized in that: the preparation method of the mulberry extract comprises the following steps: weighing fresh mulberry fruits, pulping, adding distilled water, performing ultrasonic-assisted extraction at normal temperature, filtering the extraction solution, and concentrating the filtrate under reduced pressure to obtain red paste extracts respectively.
5. The preparation method of the health preserving composite tea rich in Chinese herbal medicine components as claimed in claim 3, characterized in that: the preparation method of the coix seed powder comprises the following steps: cleaning, draining, drying at 50 + -1 deg.C in a drying oven to constant weight, coarse pulverizing with a universal pulverizer, sieving with 60 mesh sieve, and grinding with a fine grinder.
6. The preparation method of the health preserving composite tea rich in Chinese herbal medicine components as claimed in claim 5, which is characterized in that: the refining conditions are as follows: the amplitude is 5.5mm, the working mode is turnover type, and the high-frequency vibration crushing is carried out for 1min at the room temperature of 25-28 ℃ by adopting a circulating refrigeration system.
7. The preparation method of the health preserving composite tea rich in Chinese herbal medicine components as claimed in claim 3, which is characterized by comprising the following steps: the prepared particles in step (4) are 80 mesh in size.
8. The health tea prepared by the preparation method of the health composite tea rich in Chinese herbal medicine components in any one of claims 3-7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211010440.6A CN115336691A (en) | 2022-08-23 | 2022-08-23 | Preparation method of health-preserving composite tea rich in Chinese herbal medicine components |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211010440.6A CN115336691A (en) | 2022-08-23 | 2022-08-23 | Preparation method of health-preserving composite tea rich in Chinese herbal medicine components |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115336691A true CN115336691A (en) | 2022-11-15 |
Family
ID=83953165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211010440.6A Pending CN115336691A (en) | 2022-08-23 | 2022-08-23 | Preparation method of health-preserving composite tea rich in Chinese herbal medicine components |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115336691A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105623995A (en) * | 2016-03-06 | 2016-06-01 | 胡伯虎 | Large-fruited Chinese hawthorn appetizer wine or drink and preparation method thereof |
CN106215030A (en) * | 2016-08-18 | 2016-12-14 | 宿松县众创茶业种植专业合作社 | A kind of antioxidation blood fat reducing Folium Camelliae sinensis and preparation method thereof |
-
2022
- 2022-08-23 CN CN202211010440.6A patent/CN115336691A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105623995A (en) * | 2016-03-06 | 2016-06-01 | 胡伯虎 | Large-fruited Chinese hawthorn appetizer wine or drink and preparation method thereof |
CN106215030A (en) * | 2016-08-18 | 2016-12-14 | 宿松县众创茶业种植专业合作社 | A kind of antioxidation blood fat reducing Folium Camelliae sinensis and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
刘继洪: "《常见老年病食疗精选》", 31 October 2015 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103340334B (en) | Freshwater fish feed and preparation method thereof | |
CN101695376B (en) | Health food for preventing diabetes | |
CN103262967B (en) | Snow pear, banana and corn jam and preparation method thereof | |
CN101664068B (en) | Soybean milk powder and preparation method | |
CN107296949A (en) | Integration of drinking and medicinal herbs compound formulation and its preparation method and application | |
CN107114663A (en) | A kind of fruits and vegetables nourishing the stomach ground rice and preparation method thereof | |
US20200147166A1 (en) | Health supplement food for promotion of hair growth, mitigation and alleviation of hair loss, regulation of blood glucose, and alleviation and relief of gastric disorder symptoms | |
KR101855421B1 (en) | Agricultural products with a pharmacological action and the mycelium mixtures are fermented food composition method of preparing the same | |
CN110089600B (en) | A tea prepared from radix Puerariae and folium Nelumbinis and its preparation method | |
CN114631632B (en) | Rosa roxburghii composition for protecting liver and dispelling effects of alcohol, and preparation and application thereof | |
CN107751993A (en) | A kind of antifatigue cream taste and preparation method thereof | |
CN100333668C (en) | Beverage with bamboo and siberian solomoseal rhizome its preparation method | |
EP3881685A1 (en) | Ceratonia siliqua fruit composition and preparation method therefor and use thereof | |
CN102511876B (en) | Hawthorn red jujube thick syrup and production process thereof | |
Nguyen | Combining a number of medicinal herbs in order to treat fatty liver disease | |
KR102211523B1 (en) | Pills for health foods and methods for manufacturing same | |
CN103461565B (en) | Winter health preserving early tea teabag | |
CN107384680B (en) | Passion fruit and longan fruit wine and brewing method thereof | |
CN115336691A (en) | Preparation method of health-preserving composite tea rich in Chinese herbal medicine components | |
CN108522731A (en) | A kind of Amomum cardamomum flavor Noni fruit milk tea powder | |
KR102215936B1 (en) | Functional Food Composition Ssangwhatang for Fatigue Recovery comprising Chestnut and Manufacturing method of thereof | |
KR20110029473A (en) | Functional liquid containing lactic acid bacteria and preparation method thereof | |
CN111134260A (en) | Dendrobium officinale plant beverage and preparation method thereof | |
KR102515041B1 (en) | Health food using sprout ginseng and manufacturing method of the same | |
CN1709165A (en) | Health-care tea for regulating fat and stabilizing pressure and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221115 |